Subtherapeutic itraconazole and voriconazole levels in children with cystic fibrosis

被引：12
作者：
Bentley, S. [1 ]
Gupta, A. [1 ]
Balfour-Lynn, I. M. [1 ]
机构：
[1] Royal Brompton Hosp, Dept Paediat, London SW3 6LY, England
来源：
JOURNAL OF CYSTIC FIBROSIS | 2013年 / 12卷 / 04期
关键词：
Cystic fibrosis; Antifungal therapy;
D O I：
10.1016/j.jcf.2012.09.007
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：418 / 419
页数：2
相关论文
共 5 条
  • [1] Treatment of Aspergillus fumigatus in Patients with Cystic Fibrosis: A Randomized, Placebo-Controlled Pilot Study
    Aaron, Shawn D.
    Vandemheen, Katherine L.
    Freitag, Andreas
    Pedder, Linda
    Cameron, William
    Lavoie, Annick
    Paterson, Nigel
    Wilcox, Pearce
    Rabin, Harvey
    Tullis, Elizabeth
    Morrison, Nancy
    Ratjen, Felix
    [J]. PLOS ONE, 2012, 7 (04):
  • [2] Pharmacokinetics and safety of itraconazole in patients with cystic fibrosis
    Conway, SP
    Etherington, C
    Peckham, DG
    Brownlee, KG
    Whitehead, A
    Cunliffe, H
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (05) : 841 - 847
  • [3] Cystic Fibrosis Trust, 2009, ANTI TREATM CYST FIB
  • [4] Drug disposition in cystic fibrosis
    Rey, E
    Tréluyer, JM
    Pons, G
    [J]. CLINICAL PHARMACOKINETICS, 1998, 35 (04) : 313 - 329
  • [5] Allergic bronchopulmonary aspergillosis in cystic fibrosis - State of the art: Cystic Fibrosis Foundation Consensus Conference
    Stevens, DA
    Moss, RB
    Kurup, VP
    Knutsen, AP
    Greenberger, P
    Judson, MA
    Denning, DW
    Crameri, R
    Brody, AS
    Light, M
    Skov, M
    Maish, W
    Mastella, G
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 : S225 - S264
1